DNA-based vaccines against cancer
DNA-based vaccines against cancer
Efficient antigen expression in vivo is an essential step in eliciting anti-tumour immunity by DNA vaccines. In this study we showed that inclusion of either Intron A of the human cytomegalovirus immediate early gene promoter or the SV40 promoter/enhancer in the vaccine vectors could increase the expression of an idiotypic (Id) Ig-FrC fusion construct in vitro, and incorporation of both components resulted in the highest expression level. Vaccination studies in mice showed that the levels of antigen expression in vitro correlated with the antibody responses in vivo. Importantly, higher antibody responses appeared to confer better protection against tumour challenge. Furthermore, higher level of antigen expression could also improve CD8+ T cell responses and provide better tumour protection when a DNA vaccine encoding that AH1 CTL epitope (pDOM-AH1) was tested. Together, the data strongly suggest that increasing antigen expression is an effective approach to augmenting the potency of DNA tumour vaccines.
One strategy for enhancing the efficacy of tumour vaccines is to link to tumour antigen to a pathogen-derived antigen that can activate potent cognate CD+ T cell help. In this study, we explored the utilities of the B subunit of Escherichia coli heat-labile enterotoxin (EtxB). EtxB is not only a highly immunogenic molecule itself, but also can act as a potent adjuvant or carrier to increase immune responses to other antigens. Fusion of EtxB to a tumour antigen should provide linked CD4+ T cell help. Moreover, EtxB can directly exert potent immuno-modulatory activities on lymphocytes and antigen presenting cells. A further attraction is its potential to enhance activation of T cell responses by enhancing antigen via receptor-mediated mechanism.
University of Southampton
Chen, Caleb Gonshen
9b7f7128-c776-409d-ac80-d0af518f1344
2004
Chen, Caleb Gonshen
9b7f7128-c776-409d-ac80-d0af518f1344
Chen, Caleb Gonshen
(2004)
DNA-based vaccines against cancer.
University of Southampton, Doctoral Thesis.
Record type:
Thesis
(Doctoral)
Abstract
Efficient antigen expression in vivo is an essential step in eliciting anti-tumour immunity by DNA vaccines. In this study we showed that inclusion of either Intron A of the human cytomegalovirus immediate early gene promoter or the SV40 promoter/enhancer in the vaccine vectors could increase the expression of an idiotypic (Id) Ig-FrC fusion construct in vitro, and incorporation of both components resulted in the highest expression level. Vaccination studies in mice showed that the levels of antigen expression in vitro correlated with the antibody responses in vivo. Importantly, higher antibody responses appeared to confer better protection against tumour challenge. Furthermore, higher level of antigen expression could also improve CD8+ T cell responses and provide better tumour protection when a DNA vaccine encoding that AH1 CTL epitope (pDOM-AH1) was tested. Together, the data strongly suggest that increasing antigen expression is an effective approach to augmenting the potency of DNA tumour vaccines.
One strategy for enhancing the efficacy of tumour vaccines is to link to tumour antigen to a pathogen-derived antigen that can activate potent cognate CD+ T cell help. In this study, we explored the utilities of the B subunit of Escherichia coli heat-labile enterotoxin (EtxB). EtxB is not only a highly immunogenic molecule itself, but also can act as a potent adjuvant or carrier to increase immune responses to other antigens. Fusion of EtxB to a tumour antigen should provide linked CD4+ T cell help. Moreover, EtxB can directly exert potent immuno-modulatory activities on lymphocytes and antigen presenting cells. A further attraction is its potential to enhance activation of T cell responses by enhancing antigen via receptor-mediated mechanism.
Text
953677.pdf
- Version of Record
More information
Published date: 2004
Identifiers
Local EPrints ID: 465424
URI: http://eprints.soton.ac.uk/id/eprint/465424
PURE UUID: e1a46984-b247-4e6d-ac21-88f8ea8c3087
Catalogue record
Date deposited: 05 Jul 2022 00:54
Last modified: 16 Mar 2024 20:10
Export record
Contributors
Author:
Caleb Gonshen Chen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics